BioFluidica (United States)

Home - BioFluidica

CELL - AND EXOSOME - BASED LIQUID BIOPSY Cell- and exosome-based liquid biopsy is now here. As a liquid biopsy company, BioFluidica has created the future of liquid biopsy by creating LiquidScan®. *LiquidScan isolates rare cells and exosomes, making diagnostics possible for cell- and exosome-based liquid biopsy. *LiquidScan combines cutting-edge microfluidics, advanced immunoaffinity chemistries, automation hardware,